CD8A and neoplasm: However, the treatment of ApcMin/+ mice with strong iNKT cell agonists (α-GalCer and C20:2) reduced the polyp size in the small intestine thanks to iNKT cell-dependent intra-tumor activation of CD8 T cells and M1-like switch of TAMs (90).